SCHEMBL19207397

SCHEMBL19207397

CCN(C)[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 10/20 0.79
SLC6A4 P31645 10/20 0.79
SLC6A3 Q01959 10/20 0.79
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
NPC1 O15118 1/20 0.56
MLNR O43193 1/20 0.56
NR1I2 O75469 1/20 0.56
ABCB11 O95342 1/20 0.56
ESR1 P03372 1/20 0.56
CYP1A2 P05177 1/20 0.56
CHRM2 P08172 1/20 0.56
CHRM4 P08173 1/20 0.56
ABCB1 P08183 1/20 0.56
ADRB1 P08588 1/20 0.56
CYP3A4 P08684 1/20 0.56
HTR1A P08908 1/20 0.56
CHRM5 P08912 1/20 0.56
ADRA2A P08913 1/20 0.56
ADORA3 P0DMS8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22398922 0.90 SLC6A2 (0.80) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL20690372 0.90 SLC6A2 (0.80) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL6554028 0.87 SLC6A4 (0.80) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL6946811 0.87 SLC6A2 (0.65) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL10995616 0.86 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL11133286 0.86 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL9843400 0.86 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL11133547 0.86 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL6944959 0.86 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL8253409 0.86 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337182-A1 REDUCING SIDE EFFECTS OF NMDA RECEPTOR ANTAGONISTS Seelos Therapeutics, Inc. (US) 2024-03-20 EP disclosed
EP-4277635-A1 MODIFIED MIR-135, CONJUGATED FORM THEREOF, AND USES OF SAME Yeda Research and Development Co. Ltd (IL) 2023-11-22 EP disclosed
WO-2022153322-A1 MODIFIED MIR-135, CONJUGATED FORM THEREOF, AND USES OF SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2022-07-21 WO disclosed
EP-3472192-A1 SPIDER VENOM PEPTIDES AND METHODS OF USE FOR MODULATING SODIUM CHANNELS. The University of Queensland (AU) 2019-04-24 EP disclosed
EP-3411040-A1 SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION President and Fellows of Harvard College (US) 2018-12-12 EP disclosed
WO-2017219081-A1 SPIDER VENOM PEPTIDES AND METHODS OF USE FOR MODULATING SODIUM CHANNELS. THE UNIVERSITY OF QUEENSLAND (AU) 2017-12-28 WO disclosed
WO-2017136480-A1 SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-08-10 WO disclosed